Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Jul 29, 2014
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2014-07-25$4.31/sh+12,759$54,991→ 45,770 total - Exercise/Conversion
Stock Option to Buy
2014-07-25−12,759→ 0 totalExercise: $4.31Exp: 2019-12-11→ Common Stock (12,759 underlying)
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
- [F2]Stock option granted on December 11, 2009 and vests 25% per year over four years.